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C BY-NC-Abstract The synthesis, characterization and diuretic activity of four new biologically active com-
plexes of Mg(II) and VO(II) with bidentate Schiff base ligand acetazolamide–salicylaldimine (L)
obtained from the inserted condensation of 5-acetamido-1,3,4-thiadiazole-2-sulphonamide (aceta-
zolamide) with salicylaldehyde in a 1:1 molar ratio have been reported. Using this bidentate ligand
complexes of Mg(II), Mn(II), Fe(II) and VO(II) with general formula ML2 have been synthesized.
The synthesized complexes were characterized by several techniques using elemental analysis, FT-
IR, electronic spectra, TGA, mass, particle size analysis and molar conductance measurements. The
elemental analysis data suggest the stoichiometry to be 1:2 [M:L]. The molar conductance measure-
ments suggest non-electrolytic nature of the complexes. Infrared spectral data agreed with the coor-
dination to the central metal ion through deprotonated phenolic oxygen and azomethine nitrogen
atoms. On the basis of spectral studies, octahedral geometry is suggested for Mg(II), Mn(II), Fe(II)
and square pyramidal geometry is suggested for VO(II) complexes. The pure drug, synthesized
ligand and metal(II) complexes were screened for their antimicrobial activities against Eschericia
coli, Bacillus subtilis, Aspergillus niger and Aspergillus ﬂavous. The results show that the metal1 9009797554; fax: +91 755
.in (S. Ghosh).
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138 S. Ghosh et al.complexes were more active than the ligand and pure drug against these microbial species as
expected. The ligand and its Mg(II) complexes was screened for their diuretic activity also.
ª 2011 King Saud University. Production and hosting by Elsevier B.V.Figure 1 Structure of ligand.
Open access under CC BY-NC-ND license.1. Introduction
Metal complexes play an important role in many biological
systems. They have received a great attention because of their
different biological activities (Turel et al., 2000; Sakurai, 2002;
Chandra et al., 2008; Piotr et al., 2009). The development of
the ﬁeld of bioinorganic chemistry has increased the interest
in Schiff base complexes, since they have special role in biolog-
ically important species (Fu et al., 2008; Shabani et al., 2010).
In current age, the role of metal complexes has been increased
in relation to antimicrobial activities. Literature survey indi-
cates that ligand/pure drugs become more bacteriostatic on
complexation as compared to unchelated ones (Jain et al.,
2002; Hania, 2009). In view of the interest involved in Schiff
base complexes and in continuation of our work (Bhattach-
arya et al., 2005; Malik et al., 2010) the ligand acetazola-
mide–salicylaldimine Schiff base (L) has been synthesized. In
the present paper, we are reporting the synthesis and charac-
terization of ligand and its Mg(II), Mn(II), Fe(II) and VO(II)
complexes. The particle size analysis, antimicrobial activity
and diuretic activity of ligand and complexes have also been
studied.
2. Experimental
All the chemicals used were of AR/GR grade and purchased
from E-Merck (USA). Chemicals were used without any puri-
ﬁcation and Shalaks Pharmaceuticals provided acetazolamide
drug, which was used as such for the synthesis of ligand.
Elemental analyses were carried out on model 240 Perkin
elemental analyzer at CDRI (Central Drug Research Institute,
Lucknow, India). Metal contents were determined gravimetri-
cally using standard methods (Vogel, 1959). Conductivity mea-
surements were made in anhydrous DMF on a Systronic
model 305 (India) Conductivity Bridge. Magnetic susceptibil-
ity measurements of the complexes in the solid state were
determined by vibrating sample magnetometer at Centre for
Advance Technology, Indore at room temperature. The elec-
tronic spectra of the metal complexes in DMF were recorded
on a Perkin-Elmer UV WinLab Spectrophotometer at School
of Studies in Chemistry and Biochemistry, Vikram University,
Ujjain. The infrared spectra of the ligand and complexes were
recorded in KBr pellets using Perkin–Elmer FT-IR spectro-
photometer in the range of 4000–400 cm1 also at School of
Studies in Chemistry and Biochemistry, Vikram University,
Ujjain. Thermogravimetric measurements were carried out at
SICART, Gujarat in the range of 50–700 C at 20 C/min. Par-
ticle size analysis was also carried out at SICART, Gujarat
using laser diffraction particle size analyzer. The instrument
used was CILAS 1064L/D model in the range of 0.04–
500 lm. The melting points of the ligand and complexes were
recorded in open capillaries on a capillary melting point
apparatus.
The bioefﬁcacies of the synthesized compounds were tested
in vitro for growth inhibitory against Eschericia coli, Bacillus
subtilis, Aspergillus niger and Aspergillus ﬂavous. Agar growthfood poison technique (Kumar et al., 2003) and ﬁlter paper disc
method (Dubey, 2002) were employed to evaluate antifungal
and antibacterial activities, respectively. Streptomycin and
Grisofulvin were used as a standard for antibacterial and anti-
fungal activities respectively at 500 ppm concentrations.
The diuretic activity of Mg(II) complex was tested in white
albino mice at Jawaharlal Nehru Cancer Hospital and Re-
search Centre, Bhopal. Mice were fed with standard rodent
pallet diet and acidiﬁed double distilled water. The selected test
compound, ligand and standard drug acetazolamide (AZM) at
a dose of 0.24 mg suspended in 0.5% gum acacia were admin-
istrated to animals of respective group. One group of animal
was taken as control. For the measurement of weight of urine,
Whatman no. 1 ﬁlter paper was used. The urine weight was re-
corded after 2 h.
2.1. Synthesis of the ligand (acetazolamide–salicylaldimine)
Equimolar (0.01 M) solutions of pure drug (0.22 g) and sali-
cyladehyde (0.14 ml) were separately dissolved in methanol–
water mixture (1:1) and reﬂuxed for four hours and kept for
a day. Pale yellow crystals of acetazolamide Schiff base were
formed in the reaction mixture which were ﬁltered and washed
thoroughly with 50% methanol–water mixture, dried over vac-
uum and weighed. Melting point of Schiff base was recorded
(Fig. 1).
2.2. Ligand–metal ratio and stoichiometry
For the synthesis of complexes, ligand–metal ratio was con-
ﬁrmed by conductometric titrations using monovariation
method on Systronics conductivity meter using dip-type elec-
trode. Conductometric titrations supported 2:1 (L:M) ratio
in the complex which was further supported by Job’s method
(Job, 1928) of continuous variation as modiﬁed by Turner
and Anderson (Turner and Anderson, 1949). The stability con-
stants and free energy change values were also calculated.
2.3. Synthesis of complexes
For the synthesis of complexes, 0.02 mol acetazolamide–
salicylaldimine (L) solution was prepared in 60% acetone–
water solvent and reﬂuxed for four hours with 0.01 mol
solution of metal salts separately. The reﬂuxed solutions were
kept for some days. Solid crystalline compounds appeared in
the solution, which were ﬁltered, washed with 60% acetone–
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plexes was recorded.
3. Results and discussion
The analytical data of the complexes and their molar conduc-
tance values are given in Table 1. All these complexes are ana-
lyzed for 1:2 stoichiometry of the type ML2. On the basis of
these characterizations it has been found that all the complexes
are non-hygroscopic, stable at room temperature, insoluble in
water but fairly soluble in DMSO. The molar conductance val-
ues of these complexes are too low to account for their electro-
lytic behavior (Kumar et al., 1994).
3.1. Spectral studies of ligand and its complexes
3.1.1. IR spectra
The relevant spectral bands and their assignments are recorded
in Table 2. The IR spectra of the complexes indicate that the
ligand behaves as bidentate and the metal coordinates via azo-
methine nitrogen and phenolic –OH groups. The shift of vC‚N
to lower wave number by 30–40 cm1 in the complexes indi-
cates that these groups are involved in complexation (Shankar
et al., 2009). The ligand shows strong band at 3410 cm1 due
to phenolic –OH group (Siddapa et al., 2008). This band is ab-
sent in all the metal complexes indicating the involvement of
this group in complex formation (Reddy et al., 2006). More-
over, the shift of the vC–O phenolic bands from 1280 cm
1 in
ligand to 1280–1296 cm1 in the spectra of metal complexes
supports the coordination of the phenolic oxygen atom to
the metal ion (Zaman et al., 2006). The Mg(II), Mn(II) and
Fe(II) complexes shows a broad band in the region between
3500 and 3538 cm1 suggesting the presence of coordinated
water (Arunachalam et al., 2009). The bands for vM–O modes
(Jose et al., 2008) appeared in the range of 508–520 cm1 in
all the complexes. The presence of sharp band in the region
450–460 cm1 in the spectra of all the complexes assigned to
vM–N mode (Rai et al., 2003), further support the involvementTable 1 Elemental analysis, color, melting points and conductance
S. no. Ligand/
complexes
Elemental analysis (%): found (calcd.)
C H N S
1 L 39.01 (40.46) 4.08 (3.06) 18.21 (17.16) 19.50
2 [MgL2(H2O)2] 37.08 (37.18) 2.63 (2.53) 15.69 (15.77) 18.00
3 [MnL2(H2O)2] 35.08 (35.68) 2.33 (2.97) 15.29 (15.14) 17.10
4 [FeL2(H2O)2] 34.79 (35.59) 2.71 (2.43) 15.02 (15.09) 16.91
5 VOL2 37.16 (36.82) 2.47 (2.51) 15.97 (15.62) 18.26
Table 2 IR spectral data (cm1) of ligand and its complexes.
S. no. Ligand/complexes vN–H vC‚N
1 C11H10N4O4S2 3301 1610
2 C22H22N8O10S4Mg 3300 1572
3 C22H22N8O10S4Mn 3240 1575
4 C22H22N8O10S4Fe 3304 1578
5 C22H18N8O8S4VO 3300 1580of nitrogen atom in coordination (Budhani et al., 2010). In
addition to these bands VO(II) complex exhibits the character-
istic stretching frequency for V‚O at 952 cm1 (Garg et al.,
2009).
3.1.2. Magnetic susceptibility and electronic spectra
The magnetic moment obtained for the oxovanadium (II)
complex at room temperature is 1.77 B.M. (Chohan et al.,
2010) and its electronic spectra displayed bands at 13,986,
17,094 and 21,740 cm1 assigned for 2B2ﬁ 2E, 2B2ﬁ 2B1
and 2B2ﬁ 2A1 transitions respectively (Revansiddapa et al.,
2009). These value suggest the square pyramidal geometry
for VO(II) complex (Sein et al., 1997). Mn(II) complex showed
a value of 5.38 B.M., which is slightly lower than spin only
value of 5.92 B.M. for high spin octahedral Mn(II) complexes
(Sahu et al., 1979). The electronic spectrum of Mn(II) complex
shows four weak bands at bands at 16,000, 19,810, 20,746 and
26,740 cm1 which can be assigned to 6A1gﬁ 6T1g, 6A1gﬁ
4T2g,
6A1gﬁ 4Eg and 6A1gﬁ 4T1g respectively, in an octahe-
dral ﬁeld of Mn(II) ion (Lever, 1973). The magnetic moments
of Fe(II) complex is 5.78 B.M., which supports its high spin
octahedral geometry (Patel et al., 2000). The electronic spec-
trum of Fe(II) complex shows two bands. The bands at
10,820 cm1 may be assigned to 5T2gﬁ 5Eg transition and
the other at 20,490 cm1 to charge transfer (Spinu et al.,
2008). The Mg(II) complex is found to be diamagnetic with
coordination number six around the central metal ion (Prasad
et al., 2006).
3.1.3. Thermogravimetric studies
The thermogravimetric measurements of Mg(II) and Fe(II)
complexes were carried out at a rate of 20 C min1. The
TGA results reveal that complexes showed slight depression
near 170–200 C. The weight loss at this temperature range is
found to be equivalent to two water molecules for these com-
plexes indicating them to be coordinated water (Nikolaev
et al., 1969; Patel et al., 2007) in conformity with our earlier
observations from analytical and IR spectral investigation.data for ligand and metal complexes.
M.p. (oC) Color Molar conductance
(X1 cm2 mol1)
M
(19.61) – 242 Pale yellow –
(18.02) 3.38 (3.42) 250 White 15.8
(17.30) 7.38 (7.43) 355 Brown 15.3
(17.25) 7.81 (7.53) 360 Black 10.4
(17.85) 7.26 (7.10) 230 Yellow 12.5
vC–O vC‚O vM–N vM–O
1280 1680 – –
1286 1679 457 511
1288 1677 450 515
1290 1680 460 520
1296 1677 458 508
Figure 2 Mass spectrum of VO(II) complex.
Table 3 Particle size measurement of pure drug, ligand and its
complexes.
S. no. Sample code Particle size (lm)
1 AZM 4.16
2 L 4.01
3 [MgL2(H2O)2] 2.76
4 VOL2 2.96
140 S. Ghosh et al.Thereafter, the complexes showed rapid degradation presum-
ably due to decomposition of the organic constituents (Kesh-
van et al., 2001; Ravinder et al., 2006). The decomposition
continues upto 500 C and ﬁnally stable metal oxides are
formed (Naik et al., 2008).
3.1.4. Mass spectra
The mass spectrum of VO(II) complex shows a molecular ion
peak at m/z 718 (I) due to [(VO(L)2]
+ which suggests the
monomeric nature of the complex (Gudasi et al., 2009) and
conﬁrms the proposed formula (Liton et al., 2006). Other
peaks of appreciable intensity observed at m/z values of 376
(II) due to (VL)+, at 348 (III) due to the loss of N2 from
(II), at 317 (IV) due to loss of NO from (III) and at 267 (V)
due to [V(C9H6O3NS2)]
+ (Fig. 2). The base peak at 185 may
be due to metal ion linked to the ligand moiety, i.e.
[V(C7H4NO)]
+. The relative intensities of these peaks give
an assessment of the stabilities of the various fragments (Shar-
ma et al., 2008; Zhi et al., 2008).
3.1.5. Particle size analysis
To ﬁnd out the maximum efﬁciency of the drugs and their me-
tal complexes, studies on the particle size analysis are being
considered very helpful (Allen, 1990). The bioavailability of
low solubility drug is often intrinsically related to the drug par-
ticle size. Smaller particle size of the complexes is responsible
for the enhanced solubility of the drug (Dua et. al., 2007). Par-
ticle size and rate of dissolution not only affects the peak time
and level, but it may also affect the apparent pattern of drug
pharmaco-kinetics. The results of the particle size analysis car-
ried out for the pure drug, ligand and its Mg(II) and VO(II)
complexes have been recorded in Table 3. These results reveal
that after complexation, the size of the ligand and complexesgot reduced to much extent as compared to their parent drug
acetazolamide (AZM). As it is evident that smaller size leads
to better absorption, we conclude that the smaller size of the
complexes of these drugs may enhance their absorption thus
leading to increased potency of the drug if given in the form
of complexes (Shekunov et al., 2007).
3.1.6. Antimicrobial activity
Antimicrobialial activity of the ligand and their metal com-
plexes are given in Table 4. Better activities of the metal com-
plexes as compared to the ligand can be explained by chelation
theory. The theory explains that decrease in polarizability of
the metal could enhances the liophilicity of the complexes
which leads to the breakdown of permeability of the cells
resulting in interference with normal cell processes (Collins
et al., 1976). This indicates that chelation increases the antimi-
crobial activity (Lakshmi et al., 2009).
The results of antibacterial activity reveal that the activity
zone of inhibition for the complexes against Escherichia coli
is higher as compared to the ligand. VO(II) complex of the li-
gand showed higher activity with 24 mm inhibition whereas
the standard drug Streptomycin showed 15 mm inhibition at
Table 5 Diuretic screening data of the pure drug, ligand and its complexes
Group Ligand/complexes Average vol. of urine (ll) Final average (ll)
1:00 pm 3:00 pm 5:00 pm
I Control 97.72 160.86 68.30 180.96 ± 47.293
II AZM 113.55 184.64 109.79 135.99 ± 42..171
III L 74.94 208.80 170.77 151.50 ± 68.978
IV [MgL2(H2O)2] 306.07 314.40 355.15 355.21 ± 26.264
Table 4 Antimicrobial screening data of the ligand L and its complexes.
S. no. Compound/complex Antibacterial zone of inhibition (mm) Antifungal zone of inhibition (mm)
E. coli B. subtilis A. niger A. ﬂavous
1 L 11.20 11.18 11.48 10.38
2 [MgL2(H2O)2] 20.14 17.89 15.76 16.41
3 [MnL2(H2O)2] 13.17 12.89 13.45 14.33
4 [FeL2(H2O)2] 14.82 13.22 8.00 11.47
5 VOL2 24.00 15.78 17.00 21.22
6 Streptomycin 15.38 16.00 – –
7 Grisofulvin – – 19.38 18.22
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complexes against Bacillus subtilis showed higher activity as
compared to the ligand. Magnesium complex of the ligand
showed higher activity with 17.89 mm inhibition whereas the
standard drug Streptomycin showed only 16 mm inhibition
at the same concentration of the test drug.
Antifungal activity of ligand and its metal complexes were
screened against Aspergillus niger, Except Fe(II) complex with
8 mm inhibition, these complexes showed higher activity with
12–17 mm inhibition than the ligand which showed only
11.48 mm inhibition at the same concentration as that of the
test drug. However, ligand and their complexes showed lower
activity as compared to standard drug Grisofulvin with
19.38 mm inhibition at the same concentration.
Antifungal activity studies of ligand and its complexes
against Aspergillus ﬂavous showed that all the complexes with
11.47–21.22 mm inhibition showed higher activity than the li-
gand which showed only 10.38 mm inhibition only. VO(II)
complex showed higher activity than standard drug which
showed 18.22 mm inhibition at the same concentration as that
of the test drug.Figure 3 M=M3.1.7. Diuretic activity
The diuretic activity of the Mg(II) complex was tested in white
albino mice and recorded in Table 5. The result revealed that
metal complex has more diuretic activity as compared to the
respective ligand and pure drug (Figs. 3 and 4). Thus it is re-
vealed that complexation can increase the diuretic activity of
the parent drug (Brujmincx and Sodler, 2008).
4. Conclusion
Hence on the basis of elemental analysis, magnetic moment
data, conductivity measurements and spectral studies we pro-
posed the following structures for complexes. All the synthe-
sized metal complexes have shown biological activities
against the tested pathogenic microbial species. To counter
the increased microbial disease to the rapid growth in popula-
tion, investigations of the antimicrobal activities of the ligands
and their metal complexes would be very useful to control
these harmful diseases. The present work will be extended to
the synthesis of other metal complexes and their biological
activities.gII, MnII, FeIII.
Figure 4 Vanadyl complex of acetezolamide-salicyladimine.
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